Holistic Integrative Oncology

OCT 19, 2026 · JOURNAL ARTICLE

Erasing the invisible: targeting persister cells to cure minimal residual disease

Holistic Integrative Oncology

Abstract Despite revolutionary advances in immunotherapy and targeted therapies, tumor recurrence driven by minimal residual disease (MRD) and drug-tolerant persister (DTP) cells r

OCT 19, 2026 · JOURNAL ARTICLE

Synergistic strategies of tumor ablation and immunotherapy in hepatocellular carcinoma: mechanisms, clinical translation, and perspectives

Holistic Integrative Oncology

Abstract Hepatocellular carcinoma (HCC) remains the third leading cause of cancer-related mortality worldwide, accounting for over 85% of primary liver cancers. Locoregional ablati

SEP 28, 2026 · JOURNAL ARTICLE

Advances in molecular targets for oncologic radionuclide therapy

Holistic Integrative Oncology

Abstract Oncologic radionuclide theranostics integrates molecular imaging with targeted radionuclide therapy through target-specific ligands, allowing a shared molecular target to

AUG 14, 2026 · JOURNAL ARTICLE

CACA guidelines for the management of adult cancer pain

Holistic Integrative Oncology

This is a professional guideline developed by the China Anti-Cancer Association to standardize cancer pain assessment, diagnosis, and multimodal management across the disease trajectory.

AUG 11, 2026 · JOURNAL ARTICLE

Paclitaxel liposome with anti–HER-2 drugs as first-line therapy for recurrent/metastatic HER-2–positive breast cancer: a real-world study

Holistic Integrative Oncology

Real-world retrospective cohort with substantial sample size and mature follow-up reporting clinically relevant survival outcomes, but lacks randomized control and prospective design needed for practice-changing or strong evidence.